DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Senores Pharmaceuticals Limited — Analyst/Investor Meet Para A-XBRL

NSE 3 hrs ago·20 Aug 2026, 1:07 pm

Senores Pharmaceuticals L

Senores Pharmaceuticals Limited has informed stock exchanges that it will hold a meeting with analysts and institutional investors. This event is part of the company's regular practice to update the market on its business developments.

For investors, this meeting is a key opportunity to gain clarity on the company's future strategy and performance outlook. It provides a platform to hear management discuss their plans directly, which can help in assessing the company's direction and potential growth.

Investors should watch for any updates regarding the company's operational roadmap, financial targets, or new product developments shared during the interaction. This information will be crucial for understanding how the company plans to navigate the current market environment.